NanoViricides Inc. (NNVC)
NNVC trades on NYSE in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$1.32
+3.13% on the day
Market cap
$33.7M
Nano cap
Revenue · 2026
$0
No prior year to compare
Net income · 2026
-$8.2M
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax), period ending 2026-06-30, https://www.sec.gov/Archives/edgar/data/1379006/000110465926111390/0001104659-26-111390-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), period ending 2026-06-30.
Profile
| Field | Value |
|---|---|
| Ticker | NNVC on NYSE |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0001379006 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials · 2026
| Line | Value |
|---|---|
| Revenue | $0 |
| Net income | -$8.2M |
| Operating income | Not in SEC XBRL data |
| Net margin | Needs revenue and net income |
| Operating margin | Operating income not reported |
| Revenue growth | No prior-year revenue to compare |
| Cash | Not in SEC XBRL data |
| Total assets | Not in SEC XBRL data |
| P/E (computed) | Net income was not positive |
| P/S (computed) | Needs market cap and revenue |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B3 | 2026-09-03 |
| Latest annual report | 10-K | 2026-09-28 |
| Latest quarterly / interim | 10-Q | 2026-05-15 |
| Latest current report FORM 8-K | 8-K | 2026-09-29 |
| Latest proxy | DEF 14A | 2026-10-08 |
Source: SEC EDGAR submissions feed, 555 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| IBO | Impact BioMedical Inc. | $3.98 | -1.24% | $34.0M |
| CRVO | CervoMed Inc. | $2.27 | -9.56% | $34.3M |
| JAGX | Jaguar Health Inc. | $4.16 | -10.35% | $32.5M |
| GRDX | GridAI Technologies Corp. | $4.55 | -2.36% | $32.4M |
| CPHI | China Pharma Holdings Inc. | $0.7514 | -13.53% | $32.3M |
| BCTX | BriaCell Therapeutics Corp. Common Shares | $3.71 | -4.13% | $32.3M |
| RMTI | Rockwell Medical Inc. | $7.85 | +3.70% | $31.6M |
| FLNA | Filana Therapeutics Inc. | $0.7434 | -3.39% | $35.9M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier